Please login to the form below

Not currently logged in
Email:
Password:

NeuroTherm appoints Gregory Cash as president and CEO

Joins pain management device manufacturers from HeartSine

Gregory Cash has been appointed president and CEO of US-based pain management device company NeuroTherm.

He joins from HeartSine Technologies, where he also served as president and CEO.

“This is a key appointment at an important time for NeuroTherm, and we are certain that Greg's leadership combined with his strategic vision  and experience make him the right person to lead the company through the next phase of rapid growth and development,” said Eric Bacon, chair of the board of directors at NeuroTherm.

Prior to his time at HeartSine, Cash served in numerous senior management roles of progressive responsibility in the US, Asia and Europe.

“While there are many challenges facing the medical device industry as a whole, NeuroTherm is poised for strong growth and will continue to make a positive difference in patients' lives,” said Cash.

24th September 2012

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
WCG

WCG is an independent, global agency specialising in healthcare communications. Our value as a company is about being the positive...

Latest intelligence

More of the same: The importance of strategic communications planning for biosimilar entry
GCI Health's Hannah Morris considers the importance of strategic communications planning for biosimilar entry, a market anticipated to deliver between €8-26bn in savings across the European Union by 2020....
Online Physician Communities
How can pharma realise the power of digital?
Firstly, by making it owned and driven by the most senior leadership team in the business...
Remapping the market: Does Pharma's global model need a shake up?
For patients, carers and professionals, wherever they are in the world, digital technology is inherent in their everyday lives. Digital is, so to speak, a global language. The success of...